Experts call for BP treatment overhaul

Clinical decisions on blood pressure treatment should be informed by cardiovascular risk and not blood pressure alone, say the authors of a new landmark study.

Published in The Lancet, the analysis stratifies outcomes of  blood pressure treatment according to cardiovascular risk in a number of trials involving over 50,000 patients.

It finds that use of blood pressure drugs cuts the absolute risk of a major cardiovascular event